Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Biomedical Inc., a pioneer in digital health, announced today that the United States Patent Office will award U.S. Patent Number 8114021 to Proteus. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback